Literature DB >> 2897568

Does maintenance therapy keep duodenal ulcers healed?

E J Boyd1, J G Penston, D A Johnston, K G Wormsley.   

Abstract

34 patients were endoscopically reexamined once a month while receiving ranitidine 150 mg at night to sustain remission of a duodenal ulcer. The cumulative recurrence rate after 1 year of maintenance treatment was 48%. 71% of recurrences were painless when first detected. The monthly percentage probabilities for asymptomatic ulcers rehealing, remaining unchanged, and causing pain were 33%, 63%, and 4%, respectively. Because painless ulcers may reheal, the number of ulcer recurrences detected during maintenance trials depends on the frequency of endoscopic reexamination of symptomless patients. Endoscopic examination of symptomless patients every 6 months would have failed to detect nearly half of all recurrences in this study. Thus an accurate assessment of the true incidence of asymptomatic (and, therefore, total) recurrences requires frequent endoscopic re-examination of symptomless patients. The clinical value of maintenance treatment should be judged by prevention of symptoms and complications, since it is not possible--either practically or mathematically--to determine the true incidence of ulcer recurrence, and because asymptomatic recurrences are irrelevant, provided maintenance treatment is continued.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897568     DOI: 10.1016/s0140-6736(88)92131-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Helicobacter pylori and duodenal ulcer: Guilty as charged.

Authors:  S Shafran; J Conly
Journal:  Can J Infect Dis       Date:  1994-11

2.  Relapse rates after duodenal ulcer healing--apples or pears?

Authors:  D A Johnston; I N Marks
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 3.  Asymptomatic peptic ulcer disease. Is it worth looking for?

Authors:  R Corinaldesi; R De Giorgio; A Paternicò; V Stanghellini
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 4.  Treatment of duodenal ulceration: reflections, recollections, and reminiscences.

Authors:  K D Bardhan
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

5.  Alteration of H2 receptor sensitivity in duodenal ulcer patients.

Authors:  I N Marks
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

Review 6.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

7.  Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse.

Authors:  D D Kerrigan; M E Taylor; N W Read; A G Johnson
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

8.  Two year maintenance treatment of duodenal ulcer disease with ranitidine 150 mg: a prospective multicentre randomised study. GEMUD (Groupe d'Etude de la Maladie Ulcéreuse Duodénale).

Authors:  P Ruszniewski; A Slama; M Pappo; M Mignon
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

Review 9.  Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.

Authors:  K D Bardhan
Journal:  Yale J Biol Med       Date:  1996 May-Jun

10.  Susceptibility of Helicobacter pylori to the antibacterial activity of manuka honey.

Authors:  N al Somal; K E Coley; P C Molan; B M Hancock
Journal:  J R Soc Med       Date:  1994-01       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.